Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Medicas UIS
Print version ISSN 0121-0319
Abstract
TOBON-MARULANDA, Flor Ángela; LOAIZA-OCAMPO, Jessica and ROJAS-DURANGO, Yesenia Andrea. Antiretrovirals drug supply management evaluation at a health care institution in Medellín-Colombia 2013. Medicas UIS [online]. 2016, vol.29, n.2, pp.11-20. ISSN 0121-0319. https://doi.org/10.18273/revmed.v29n2-2016001.
Introduction: there is the need to promote rational drug supply, according to the patient's need, from the comprehensive management of drug-therapeutic monitoring quality and a perspective of risk by the use a drug. Objective: to analyze antecedents in perspective to the integrated management supply of antiretroviral drug system s in order to contribute to improving the quality of life for patients. Materials and Methods: a retrospective qualitative study was performed with hermeneutical approach, the methodological process was the review and the analysis of the protocols of the institution under the study, according to the regulations; field diary and non-participant observation processes running on the categories of Inspection, Monitoring and Control. Especially, the pharmaceutical care, this statistical analysis was performed using Spearman coefficient. Results: it was found that protocols from integrated management supply of antiretroviral drugs system are comply. Nevertheless, the pharmaceutical care to each of the patients attending the institution is poor. They showed that in the first quarter of 2013, 97.5% of the patients with antiretroviral regimens were not under pharmaceutical care in accordance with the current regulations and the provisions of the protocols. Conclusion: it is necessary to improve and strengthen the pharmaceutical care service led by a trained professional that implements other permanent, systematic, holistic and pharmaceutical care. MÉD.UIS. 2016;29(2):11-20.
Keywords : Pharmaceutical Services; Anti-Retroviral Agents; Quality Control.